Maxim PF Models 033-581/033-590
by Telectronics Pacing Systems, Inc.
510(k) K961118
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)ST | NumberK961118 | Date15 Jul 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- ST
Overview
AI-generated summary, 18 Sep 2026
The Maxim PF Models 033-581/033-590 are permanent pacemaker electrodes, designed for implantation in the cardiovascular system to regulate heart rhythm by delivering electrical impulses. These devices are classified under the FDA product code DTB and fall within the Class III regulatory category, requiring strict pre-market approval due to their critical role in cardiac function.
These electrodes are intended for single-use implantation in clinical settings such as hospitals and cardiac care units. They are supplied sterile and must be handled under aseptic conditions. The devices are subject to FDA tracking regulations as part of their 510(k) clearance (K961118), granted under 21 CFR 870.3680, and are regulated as permanent pacemaker leads for use in cardiac pacing applications.
Other devices from Telectronics Pacing Systems, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these pacemaker electrodes designed for reuse in multiple patients, or are they intended for single-use only?
The Maxim PF Models 033-581/033-590 are explicitly intended for single-use implantation in clinical settings like hospitals and cardiac care units. Since they are sterile upon supply and meant for direct cardiovascular implantation, reuse would violate aseptic conditions and compromise patient safety.
What storage conditions should I follow to maintain the sterility of these pacemaker leads?
The devices are supplied sterile and must be stored under aseptic conditions to preserve sterility. While the packaging specifics aren’t detailed, standard practice for sterile medical devices—such as keeping them in a sealed, dry environment away from direct sunlight or extreme temperatures—should be followed until immediate use.
How do I confirm these leads comply with FDA requirements for tracking and reporting?
These electrodes are subject to FDA tracking regulations as part of their 510(k) clearance (K961118) under 21 CFR 870.3680. The manufacturer, Telectronics Pacing Systems, Inc., has assigned multiple FEI numbers (e.g., 3002618605) for lot-specific tracking. Clinicians should verify the lot number against the manufacturer’s records to ensure compliance with FDA-mandated reporting requirements.
What are the key differences between the Model 033-581 and Model 033-590, and how do I select the right one?
The provided data does not specify technical differences (e.g., electrode design, lead length, or pacing configurations) between the 033-581 and 033-590 models. Selection should be based on the manufacturer’s technical documentation or consultation with a cardiologist, as these distinctions likely relate to clinical application (e.g., atrial vs. ventricular pacing) or patient-specific anatomy.